About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,362 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,362 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2361-2380 of 11,362 trials

CompletedFallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive StudyThe purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention.NCT01544049·Seattle, Washington Active not recruitingPhase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors that have a…NCT03785249·Birmingham, Alabama and 221 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

CompletedClinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test.NCT04144738·Birmingham, Alabama and 194 others

Active not recruitingStudy Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal TreatmentThe purpose of this study is to evaluate the efficacy and safety of \[Lu-177\]-PNT2002 in patients with metastatic castration-resistant prostate cancer who have progressed…NCT04647526·Tucson, Arizona and 53 others

RecruitingPersonalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin LymphomaThis phase II trial tests how well personalized reduction of chemotherapy (nivolumab, doxorubicin, vinblastine and dacarbazine) based on circulating tumor deoxyribonucleic acid…NCT06745076·Irvine, California and 5 others

RecruitingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsThis is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced solid tumors that express HER2.NCT05150691·Cerritos, California and 101 others

TerminatedA Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell LymphomaThis is a prospective, open-label, multi-center clinical study designed to evaluate the safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics, and immunogenicity of…NCT05972720·Little Rock, Arkansas and 30 others

CompletedProspective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) TrialThe purpose of this study is to compare the effect of n-acetylcysteine (NAC) plus standard care with matched placebo plus standard of care in patients diagnosed with idiopathic…NCT04300920·Tucson, Arizona and 24 others

RecruitingDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesThis phase II trial studies how well a donor stem cell transplant, treosulfan, fludarabine, and total-body irradiation work in treating patients with blood cancers (hematological…NCT04195633·Seattle, Washington

CompletedH5N1 Mix and Match With AS03Approximately 216, and up to 240, healthy males and non-pregnant females, 18 to 49 years old, inclusive, will be enrolled over a 5-month period into this multicenter, randomized…NCT01317758·Baltimore, Maryland and 3 others

CompletedCombination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00022126·Phoenix, Arizona and 50 others

CompletedPhase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet InjectorThe purpose of this study is to compare the safety, tolerability and immunogenicity of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) \[previously DENVax\] when administered…NCT01765426·Galveston, Texas and 1 other

CompletedPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well palbociclib works in treating patients with Rb positive solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with…NCT03526250·Birmingham, Alabama and 116 others

Active not recruitingA 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)To compile real-world outcomes of the Superion™ IDS in routine clinical practice.NCT04192591·Carlsbad, California and 22 others

CompletedEvaluation of the Efficacy and Safety of LevoCeptTo evaluate the effectiveness, device placement, safety, and tolerability of LevoCept to support commencing a Phase III Clinical StudyNCT02882191·Berkeley, California and 15 others

CompletedA Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid LeukemiaThis was a worldwide, three-part (Part 1: open-label, Part 2: randomized, double-blind, Part 3: extension), multi-center study to evaluate the effect of eltrombopag in subjects…NCT01440374·Phoenix, Arizona and 119 others

TerminatedSYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular LymphomaThis study evaluates the safety and efficacy of combining the EZH2 inhibitor tazemetostat with rituximab in R/R FL subjects previously treated with at least 2 standard prior…NCT04762160·Birmingham, Alabama and 19 others

CompletedHIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.Project Aware is a randomized controlled clinical trial in which individuals seeking medical or health services at sexually transmitted disease (STD) clinics are recruited to…NCT01154296·Los Angeles, California and 8 others

CompletedOSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerThe purpose of this study is to determine if OSI-774 will improve overall survival of patients with incurable stage IIIB/IV non-small cell lung cancer compared to standard of care.NCT00036647·Chicago, Illinois and 96 others

Active not recruitingPsoriasis Longitudinal Assessment and RegistryThe purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis.NCT00508547·Birmingham, Alabama and 319 others

PreviousPage 119 of 569Next

in Seattle

Heart Diseasein Seattle